← Browse by Condition
Medical Condition
cardiogenic shock
Total Trials
10
Recruiting Now
10
Trial Phases
Phase 4, Phase 3
NCT03313687
Recruiting
SafeTy and Outcome of contemPorary Treatment Strategies for Cardiogenic SHOCK
Enrollment
2,500 pts
Location
Germany
Sponsor
Universitätsklinikum Hamburg-E...
NCT05168462 Phase 4
Recruiting
Clinical Outcome and Cost-effectiveness of Reduced Noradrenaline by Using a Lower Blood Pressure Target in Patients With Cardiogenic Shock From Acute Myocardial Infarction
Enrollment
776 pts
Location
Netherlands
Sponsor
Academisch Medisch Centrum - U...
NCT06535503
Recruiting
Clinical Characteristics and Outcomes Among STEMI Patients With Cardiogenic Shock at Abu Dhabi City
Enrollment
400 pts
Location
United Arab Emirates
Sponsor
Abu Dhabi Health Services Comp...
NCT07402018
Recruiting
Intra-aortic Balloon Counterpulsation (IABC) Compliance
Enrollment
20 pts
Location
United States
Sponsor
Thomas Jefferson University
NCT04020263 Phase 3
Recruiting
Effect of Early Use of Levosimendan Versus Placebo on Top of a Conventional Strategy of Inotrope Use on a Combined Morbidity-mortality Endpoint in Patients With Cardiogenic Shock
Enrollment
610 pts
Location
France
Sponsor
Pr Bruno LEVY
NCT06662084
Recruiting
The ECMOCYP (cytochromes P450 Activity) Study
Enrollment
46 pts
Location
Switzerland
Sponsor
University Hospital, Geneva
NCT07293923
Recruiting
Magenta Elevate™ Clinical Feasibility Study in Cardiogenic Shock
Enrollment
10 pts
Location
Georgia, Israel
Sponsor
Magenta Medical Ltd.
NCT04419480
Recruiting
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
Enrollment
40 pts
Location
United States
Sponsor
Inova Health Care Services
NCT07309029
Recruiting
Pre-Emptive LAVA-ECMO for Complex High-Risk TAVR
Enrollment
30 pts
Location
United States
Sponsor
Atlantic Health System
NCT05586282
Recruiting
Role of Candidate Proteins in Capillary Leakage During Acute Circulatory Failure
Enrollment
380 pts
Location
France
Sponsor
Assistance Publique - Hôpitaux...